Published in J Antimicrob Chemother on July 03, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother (2009) 2.12
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis (2013) 2.01
Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis (2011) 1.29
Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis (2009) 1.24
Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother (2013) 1.04
High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother (2014) 0.96
Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Antimicrob Agents Chemother (2011) 0.92
Fosfomycin. Clin Microbiol Rev (2016) 0.89
Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 0.88
Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int J Infect Dis (2014) 0.88
Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats. Antimicrob Agents Chemother (2014) 0.81
Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods. Antimicrob Agents Chemother (2013) 0.80
Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysis. Antimicrob Agents Chemother (2014) 0.77
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms. Antimicrob Agents Chemother (2010) 0.77
Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model. Antimicrob Agents Chemother (2014) 0.75
Comparative Evaluation of Fosfomycin Activity with other Antimicrobial Agents against E.coli Isolates from Urinary Tract Infections. J Clin Diagn Res (2017) 0.75
Development of a novel collagen wound model to simulate the activity and distribution of antimicrobials in soft tissue during diabetic foot infection. Antimicrob Agents Chemother (2016) 0.75
Eradication of methicillin resistant S. aureus biofilm by the combined use of fosfomycin and β-chloro-L-alanine. Iran J Microbiol (2017) 0.75
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med (2008) 3.28
Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism. Pediatr Transplant (2006) 2.65
C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem (2007) 1.79
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging (2004) 1.67
Comparison of three severity scores for critically ill cancer patients. Intensive Care Med (2003) 1.57
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil. Epilepsia (2007) 1.55
Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med (2003) 1.44
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology (2006) 1.40
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res (2007) 1.35
Principles of antibiotic penetration into abscess fluid. Pharmacology (2006) 1.30
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients. Eur J Nucl Med Mol Imaging (2007) 1.25
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. Antimicrob Agents Chemother (2005) 1.22
The lower trapezius musculocutaneous flap from pedicled to free flap: anatomical basis and clinical applications based on the dorsal scapular artery. Plast Reconstr Surg (2004) 1.19
Daptomycin: a review 4 years after first approval. Pharmacology (2007) 1.15
Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother (2010) 1.15
Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis (2005) 1.12
Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother (2005) 1.10
The vascular anatomy of the tensor fasciae latae perforator flap. Plast Reconstr Surg (2009) 1.06
Verrucous carcinoma of the skin: long-term follow-up results following surgical therapy. Dermatol Surg (2004) 1.03
Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study. Nephrol Dial Transplant (2009) 1.02
AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol (2007) 1.01
Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. Int J Antimicrob Agents (2010) 1.00
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology (2007) 0.98
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother (2006) 0.96
Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.96
Extracellular concentrations of fosfomycin in lung tissue of septic patients. J Antimicrob Chemother (2010) 0.96
Efficacy and safety of current drug therapies for invasive aspergillosis. Pharmacology (2011) 0.95
Effect of severity of sepsis on tissue concentrations of linezolid. J Antimicrob Chemother (2007) 0.95
Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med (2002) 0.94
The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem (2005) 0.91
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother (2005) 0.91
Treatment of painful neuroma by resection and nerve stump transplantation into a vein. Ann Plast Surg (2003) 0.91
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med (2005) 0.90
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother (2004) 0.90
Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). AAPS J (2005) 0.90
The posterior interosseous artery in the distal part of the forearm. Is the term "recurrent branch of the anterior interosseous artery" justified? Br J Plast Surg (2004) 0.88
Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis. Scand J Infect Dis (2008) 0.87
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther (2006) 0.87
Necrotizing fasciitis after ambulatory phlebectomy performed with use of tumescent anesthesia. J Vasc Surg (2004) 0.86
Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice. J Invest Dermatol (2007) 0.86
Clinical application of the retrograde arterialized venous flap. Microsurgery (2004) 0.86
Influence of nerve stump transplantation into a vein on neuroma formation. Ann Plast Surg (2003) 0.85
Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. Antimicrob Agents Chemother (2007) 0.85
Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol (2004) 0.84
Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. Clin Sci (Lond) (2003) 0.84
Management of an unfortunate triad after breast reconstruction: pyoderma gangrenosum, full-thickness chest wall defect and Acinetobacter Baumannii Infection. J Plast Reconstr Aesthet Surg (2010) 0.83
The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem (2004) 0.83
Plasma and peritoneal dialysate levels during daptomycin therapy for peritonitis. Am J Kidney Dis (2009) 0.83
Concentrations of voriconazole in healthy and inflamed lung in rats. Antimicrob Agents Chemother (2009) 0.82
A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int J Antimicrob Agents (2007) 0.82
Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood. Pharmacology (2007) 0.82
The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats. Pharmacology (2011) 0.82
Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers. Antimicrob Agents Chemother (2004) 0.81
Reconstruction of combined defects of the Achilles tendon and the overlying soft tissue with a fascia lata graft and a free fasciocutaneous lateral arm flap. Ann Plast Surg (2003) 0.81
First experience using contrast-enhanced ultrasound to evaluate vascularisation of acellular dermal matrices after implant-based breast reconstruction. Breast J (2014) 0.81
Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis. Clin Pharmacokinet (2007) 0.81
The treatment of painful neuroma on the lower extremity by resection and nerve stump transplantation into a vein. Foot Ankle Int (2004) 0.80
The Austrian breast implant register: recent trends in implant-based breast surgery. Aesthetic Plast Surg (2014) 0.80
Development of a high-performance liquid chromatography method for the determination of caspofungin with amperometric detection and its application to in vitro microdialysis experiments. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.80
Free osteocutaneous lateral arm flap: anatomy and clinical applications. Microsurgery (2003) 0.80
Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob Agents Chemother (2004) 0.79
The effect of food on plasma and tissue concentrations of linezolid after multiple doses. Int J Antimicrob Agents (2006) 0.79
Immediate functional transfer of the latissimus dorsi myocutaneous island flap for reestablishment of elbow flexion in upper arm replantation: two clinical cases. J Trauma (2004) 0.79
Immunomodulatory effects of fosfomycin in experimental human endotoxemia. Antimicrob Agents Chemother (2007) 0.78
Determination of fosfomycin in pus by capillary zone electrophoresis. J Chromatogr A (2005) 0.78
Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects. J Antimicrob Chemother (2004) 0.78
Multidetector CTA in the quantification of internal carotid artery stenosis: value of different reformation techniques and axial source images compared with selective carotid arteriography. J Endovasc Ther (2009) 0.78
Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. J Antimicrob Chemother (2006) 0.78
The superior lateral genicular artery flap for soft-tissue reconstruction around the knee: clinical experience and review of the literature. Ann Plast Surg (2011) 0.78
Nucleophilic cross-linked, dextran coated iron oxide nanoparticles as basis for molecular imaging: synthesis, characterization, visualization and comparison with previous product. Contrast Media Mol Imaging (2014) 0.77
Multiple-dose pharmacokinetics of telithromycin in peripheral soft tissues. Int J Antimicrob Agents (2009) 0.77
Capillary electrophoresis analysis of fosfomycin in biological fluids for clinical pharmacokinetic studies. Electrophoresis (2004) 0.77
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration. J Antimicrob Chemother (2006) 0.77
S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood. Pharmacology (2007) 0.77
Passive Immunization against Congenital Cytomegalovirus Infection: Current State of Knowledge. Pharmacology (2015) 0.77
Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model. Int J Antimicrob Agents (2003) 0.77
Prospective evaluation of high-resolution MRI using gadofosveset for stent-graft planning: comparison with CT angiography in 30 patients. AJR Am J Roentgenol (2011) 0.77
Quality of life in patients with idiopathic subclavian vein thrombosis. Thromb Res (2009) 0.77
High extracellular levels of cefpirome in unaffected and infected lung tissue of patients. J Antimicrob Chemother (2010) 0.77
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. Pharmacology (2005) 0.77
The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model. Wien Klin Wochenschr (2009) 0.76
A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates. Clin Pharmacokinet (2011) 0.76
Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know! Crit Care Med (2011) 0.75
Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue. Antimicrob Agents Chemother (2005) 0.75
Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother (2007) 0.75